![Joaquín Primo on Twitter: "HEPAmet Fibrosis Score calculator https://t.co/WNyfiiFNXZ @Dr_Ampuero @mromerogomez @RocioGallegoD @HvrSspa @unisevilla @ibis_sevilla @get_ruben @jturnesv @RegistroHEPAmet @CIBERehd @AEEHLiver @EASLnews #NAFLD #NAFLDresearch ... Joaquín Primo on Twitter: "HEPAmet Fibrosis Score calculator https://t.co/WNyfiiFNXZ @Dr_Ampuero @mromerogomez @RocioGallegoD @HvrSspa @unisevilla @ibis_sevilla @get_ruben @jturnesv @RegistroHEPAmet @CIBERehd @AEEHLiver @EASLnews #NAFLD #NAFLDresearch ...](https://pbs.twimg.com/media/DaubbWjWsAApDmG.jpg)
Joaquín Primo on Twitter: "HEPAmet Fibrosis Score calculator https://t.co/WNyfiiFNXZ @Dr_Ampuero @mromerogomez @RocioGallegoD @HvrSspa @unisevilla @ibis_sevilla @get_ruben @jturnesv @RegistroHEPAmet @CIBERehd @AEEHLiver @EASLnews #NAFLD #NAFLDresearch ...
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome](https://assets.cureus.com/uploads/figure/file/338142/lightbox_82158fd0988b11ec86841deb1a69af7c-Screenshot-2022-02-28-at-16.50.20.png)
Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome
![Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/355d73f6-ab09-4fef-b4e9-0083ef9bb5d3/hepr13688-fig-0001-m.jpg)
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library
![Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD](https://www.oatext.com/img/Non-invasive-3.jpg)
Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD
![Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b90b27221a866f1a2786f6986421c23611d0efdf/3-Table1-1.png)
Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar
![NAFLD and NASH The next Tsunami in liver disease Are we ready? Mary Pat Pauly MD FACP AASLD Gastroenterology and Liver Disease Kaiser Permanente, Sacramento. - ppt download NAFLD and NASH The next Tsunami in liver disease Are we ready? Mary Pat Pauly MD FACP AASLD Gastroenterology and Liver Disease Kaiser Permanente, Sacramento. - ppt download](https://images.slideplayer.com/47/11728469/slides/slide_38.jpg)